GlassScriptPhysician profile
Morgan Smyth
NPI 1790156008
$1,102.37
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.03 · 2022: $136 · 2023: $256 · 2024: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $187.36 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $124.38 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $89.94 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $84.48 | 2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $72.58 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $71.39 | 2024 | |
| Lilly USA, LLC | $70.08 | 2023-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $66.12 | 2023-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $62.34 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.73 | 2024 | Ofev |
| Sanofi-Aventis U.S. LLC | $44.47 | 2021-2022 | |
| Mylan Specialty L.P. | $41.10 | 2023 | Yupelri |
| Pfizer INC. | $35.32 | 2023-2024 | |
| Lundbeck LLC | $21.48 | 2022 | |
| Sanofi Pasteur INC. | $18.37 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $16.95 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.74 | 2024 | Xifaxan, Trulance |
| Phadia US INC. | $16.02 | 2023 | Immunocap |
| Qiagen, LLC | $15.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Smyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.